A detailed history of Laurion Capital Management LP transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, Laurion Capital Management LP holds 248,395 shares of AGIO stock, worth $11.5 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares
248,395
Previous 364,762 31.9%
Holding current value
$11.5 Million
Previous $10.7 Million 0.42%
% of portfolio
0.13%
Previous 0.09%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$27.55 - $48.83 $3.21 Million - $5.68 Million
-116,367 Reduced 31.9%
248,395 $10.7 Million
Q1 2024

May 15, 2024

BUY
$21.32 - $34.81 $7.78 Million - $12.7 Million
364,762 New
364,762 $10.7 Million
Q1 2020

May 14, 2020

SELL
$31.52 - $53.81 $936,144 - $1.6 Million
-29,700 Closed
0 $0
Q4 2019

Feb 13, 2020

BUY
$30.08 - $50.59 $893,376 - $1.5 Million
29,700 New
29,700 $1.42 Million

Others Institutions Holding AGIO

About AGIOS PHARMACEUTICALS, INC.


  • Ticker AGIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 54,818,000
  • Market Cap $2.54B
  • Description
  • Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...
More about AGIO
Track This Portfolio

Track Laurion Capital Management LP Portfolio

Follow Laurion Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Laurion Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Laurion Capital Management LP with notifications on news.